| Oct 7, 2009 | 07:00 | Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors |
| Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr., M.D., has been appointed to its Board of Directors.
continued... |
|
| Sep 2, 2009 | 07:00 | Infinity to Present At Upcoming Conferences |
| Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences.
continued... |
|
| Aug 5, 2009 | 16:15 | Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results |
| Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reviewed recent R&D highlights, provided updated 2009 guidance, and announced second quarter 2009 financial results.
continued... |
|
| Jul 30, 2009 | 06:30 | Infinity Announces Second Quarter 2009 Results Conference Call |
| Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Infinity management will host a conference call on Thursday, August 6, 2009 at 8:30 a.m. EDT. In the conference call, management will review recent research and development and business highlights including Infinity's second quarter 2009 financial results.
continued... |
|
| Jul 23, 2009 | 16:40 | Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, Published in Journal of Medicinal Chemistry |
| Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that the chemistry and data leading to the discovery of its novel Hedgehog signaling pathway inhibitor, IPI-926, have been published in the Journal of Medicinal Chemistry. The paper, titled "Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)" and authored by Infinity's Martin R. Tremblay, Ph.D., Alfredo C. Castro, Ph.D., et al., is featured in today's issue of the journal (Volume 52, Issue 14, pages 4400-4418).
continued... |
|
| More >>
Total: 5 * all times are in the U.S. Eastern Time Zone
|
